Serum levels of ACE2 are higher in patients with obesity and diabetes.

Valur EmilssonElias F GudmundssonThor AspelundBrynjolfur G JonssonAlexander GudjonssonLenore J LaunerJohn R LambValborg GudmundsdottirLori L JenningsVilmundur Gudnason

Published in: Obesity science & practice (2020)

ACE2 levels are higher in some patient groups with comorbidities linked to COVID-19 including obesity and T2D and as such may have an emerging role as a circulating biomarker for severity of outcome in the disease.

Keyphrases

type diabetes
insulin resistance
metabolic syndrome
weight loss
high fat diet induced
coronavirus disease
angiotensin converting enzyme
angiotensin ii
weight gain
sars cov
cardiovascular disease
glycemic control
case report
adipose tissue
skeletal muscle
physical activity